55 Insider for 2015

Let's see oncology R&D cut, oncology lead trainer gets switched to diabetes division. When R&D is cut, it doesn't look like the miserable pipeline will get better or that Sanofi is really invested in onc anymore.
I'm sure some fat will be cut in useless OverpaidNM role and market access….that will be next. And what does useless change agent dbag spetrini do but analyze numbers and green vs. red accounts…cut him.
So much pathetic waste still here.

 

Yes. Fink does SUCK.